Work in my laboratory first directly demonstrated the rapid hepatic clearance of apolipoprotein B of lower molecular weight (apo B1) from rat plasma compared to apolipoprotein B of higher molecular weight (apo Bh). The use of SDS-gel filtration column chromatography enabled a direct comparison of apo B1 label in whole serum to liver homogenates, allowing a direct calculation of hepatic apo B1 clearance rates. In rats apo B1 represents a secretory protein of liver and intestine as opposed to apo Bh which is an hepatic secretory protein. Apo Bh containing secretory lipoproteins (Lps) undergo progressive delipidation and eventually apo Bh constitutes the major apo B protein of LDL. Recent experiments described in this proposed provide an explanation. The liver has a binding site for apo B1 enriched Lps which allows discrimination from apo Bh containing Lps. Hepatic recognition requires prior lipase interaction with Lps. Once bound the apo B1 enriched Lps are internalized and degraded. The apo Bh-Lps remain in the plasma in LDL with a slow catabolic rate. I propose studies using isolated liver perfusion to characterize the apo B1 hepatic binding site. These experiments will involve study of characterized Lp particles which vary in apoprotein composition. Using apo B1-Lps the binding site will be characterized in terms of affinity, saturation, turnover, apoprotein specificity and lysosomal interaction. A calculation of receptor number will be made and it will be determined whether dietary or metabolic state alters the number. Using particles of mixed composition, favorable apoprotein composition for hepatic clearance of Lps will be determined with particular interest in the role of surface protein (apo C, apo E and apo A-1) on binding of apo B1-Lps. Considering the evidence that apo E may mediate Lp interaction with liver, a reasonable hypothesis is that apo E increases the hepatic sinusoidal concentration of Lps for action as a substrate for sinusoidal lipases. Apo B1 recognition may occur only following lipase modification and apo B1 hepatic clearance would, therefore, be facilitated by apo E present on the Lp. Particle composition of apo B1-Lps is seen as critical to their eventual hepatic catabolism. These studies assume importance because of the relationship of apo B-Lps, especially IDL and LDL, in development and progression of human atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL029837-03
Application #
3340889
Study Section
Metabolism Study Section (MET)
Project Start
1983-04-01
Project End
1986-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Medicine
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Sowden, M P; Collins, H L; Smith, H C et al. (1999) Apolipoprotein B mRNA and lipoprotein secretion are increased in McArdle RH-7777 cells by expression of betaine-homocysteine S-methyltransferase. Biochem J 341 ( Pt 3):639-45
Sparks, J D; Phung, T L; Bolognino, M et al. (1998) Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia. Metabolism 47:1315-24
Van Mater, D; Sowden, M P; Cianci, J et al. (1998) Ethanol increases apolipoprotein B mRNA editing in rat primary hepatocytes and McArdle cells. Biochem Biophys Res Commun 252:334-9
Sparks, J D; Collins, H L; Sabio, I et al. (1997) Effects of fatty acids on apolipoprotein B secretion by McArdle RH-7777 rat hepatoma cells. Biochim Biophys Acta 1347:51-61
Phung, T L; Mooney, R A; Kulas, D T et al. (1997) Suppression of the protein tyrosine phosphatase LAR reduces apolipoprotein B secretion by McA-RH7777 rat hepatoma cells. Biochem Biophys Res Commun 237:367-71
Phung, T L; Roncone, A; Jensen, K L et al. (1997) Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem 272:30693-702
Phung, T L; Sowden, M P; Sparks, J D et al. (1996) Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat. Metabolism 45:1056-8
Sparks, J D; Sparks, C E (1996) Chromatographic method for isolation and quantification of apolipoproteins B-100 and B-48. Methods Enzymol 263:104-20
Schock, D; Kuo, S R; Steinburg, M F et al. (1996) An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing. Proc Natl Acad Sci U S A 93:1097-102
Sparks, J D; Phung, T L; Bolognino, M et al. (1996) Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem J 313 ( Pt 2):567-74

Showing the most recent 10 out of 35 publications